Literature DB >> 3930045

Inhibition of bone resorption in vitro by compound 48/80.

G Greenberg, S Pokress, C Minkin.   

Abstract

The mechanisms that control cycles of bone formation and bone resorption are not well understood. In this report we provide evidence that compound 48/80 is a potent inhibitor of bone resorption in vitro. Resorption was assessed by the release of calcium-45 from pre-labelled newborn mouse calvaria that were treated with compound 48/80 and/or parathyroid hormone (PTH) in organ culture. Our results demonstrate that co-incubation of calvaria with PTH plus compound 48/80 (concentrations 1-10 mcg/ml) produces a marked reduction of calcium-45 release compared to PTH alone. Furthermore, pre-incubation of calvaria with compound 48/80, for as little as three hours, inhibits resorption by subsequent treatment with PTH alone. Measurement of lactate dehydrogenase (LDH) released into the culture medium indicated that treatment with compound 48/80, at the doses and time periods studied, was not cytotoxic. This novel effect of compound 48/80 may provide a useful tool for studying the cellular mechanisms involved in the bone resorption process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930045     DOI: 10.1007/bf02553717

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Compound 48/80: a potent histamine liberator.

Authors:  W D M PATON
Journal:  Br J Pharmacol Chemother       Date:  1951-09

2.  Enhancement of phagocytosis by Compound 48/80 and its influence upon Ca++-dependent ATP-ase.

Authors:  D Falke; E M Lemmel; L S Richardson; H U Wolf
Journal:  Arzneimittelforschung       Date:  1975-08

3.  A family of long-acting depressors.

Authors:  R BALTZLY; J S BUCK
Journal:  J Am Chem Soc       Date:  1949-04       Impact factor: 15.419

4.  Selective release of histamine from rat mast cells by compound 48-80 and anitgen.

Authors:  A R Johnson; N C Moran
Journal:  Am J Physiol       Date:  1969-03

5.  Association of 45calcium with rat mast cells stimulated by 48/80: effects of inactivation, calcium and metabolic inhibition.

Authors:  D E Cochrane; D L Distel
Journal:  J Physiol       Date:  1982-09       Impact factor: 5.182

6.  Inhibition of normal and leukemic lymphocyte proliferation by compound 48/80.

Authors:  L M Patt; J C Houck
Journal:  Biochem Pharmacol       Date:  1983-02-01       Impact factor: 5.858

Review 7.  Mechanisms of histamine release in anaphylactic and anaphylactoid reactions.

Authors:  W Kazimierczak; B Diamant
Journal:  Prog Allergy       Date:  1978

8.  HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE.

Authors:  P GOLDHABER
Journal:  Science       Date:  1965-01-22       Impact factor: 47.728

9.  Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.

Authors:  C Minkin; R S Fredericks; S Pokress; R K Rude; C F Sharp; M Tong; F R Singer
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

10.  Inhibition by calcium antagonists of histamine release and calcium influx of rat mast cells: difference between induction of histamine release by concanavalin A and compound 48/80.

Authors:  T Suzuki; K Mori; M Uchida
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.